Market Tracker

05/23 10:39pm ET

Amgen Inc (NASDAQ:AMGN)

During the Trading Day
105.62 +1.09 / +1.04%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
105.62 0.00 / 0.00%
 
Volume: 85.7K

Today’s Trading

Previous close104.53
Today’s open103.10
Day’s range103.00 - 106.33
Volume3,169,432
Average volume (3 months)4,242,984
Market cap$78.4B
Dividend yield1.78%
Data as of 4:00pm ET, 05/23/2013

Growth & Valuation

Earnings growth (last year)+36.63%
Earnings growth (this year)+11.78%
Earnings growth (next 5 years)+7.70%
Revenue growth (last year)+9.57%
P/E ratio17.9
Price/Sales3.89
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences Inc-0.45-0.80%
BIIBBiogen Idec Inc-0.45-0.19%
BAXBaxter International...-0.15-0.21%
LIFELife Technologies Co...-0.16-0.22%
Data as of 4:00pm ET, 05/23/2013

Financials

Next reporting dateJuly 25, 2013
EPS forecast (this quarter)$1.74
Annual revenue (last year)$17.2B
Annual profit (last year)$4.3B
Net profit margin25.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway, MBA
Chief Financial Officer &
Executive Vice President
Jonathan M. Peacock, CA
Corporate headquarters
Thousand Oaks, California

Forecasts